When patients were stratified into two groups based on median GLIPR1 expression, there was no significant difference in overall survival between MM patients with below median (low) GLIPR1 expression and those patients with above median (high) GLIPR1 levels (P = 0.760; S1B Fig). The gene discussed is GLIPR1; the disease is Miyoshi myopathy.